An agonist of the MscL channel affects multiple bacterial species and increases membrane permeability and potency of common antibiotics

Robin Wray, Nadia Herrera, Irene R Iscla, Junmei Wang, Paul Blount

Research output: Contribution to journalArticle

Abstract

The bacterial MscL channel normally functions as an emergency release valve discharging cytoplasmic solutes upon osmotic stress. The channel opens and passes molecules up to 30 Å and its pore is the largest of any gated channel. Opening the MscL pore inappropriately is detrimental to the bacterial cell, suggesting MscL as a potential novel drug target. A small-molecule compound, 011A, has been shown to increase sensitivity of the Escherichia coli MscL channel, slow growth, and even decrease viability of quiescent cultures. The mscL gene is highly conserved and found in the vast majority of bacterial species, including pathogens. Here, we test the hypothesis that 011A can influence the growth and viability of other bacterial species, specifically Staphylococcus aureus and Mycobacterium smegmatis, in a MscL-dependent manner. Furthermore, we demonstrate that the 011A compound can increase potency of other antibiotics, presumably by permeabilizing the membrane and allowing easier access of the antibiotic into the cytoplasm. Thus, MscL activators have potential as novel broad-spectrum antibiotics or adjuvants that work with antibiotics to selectively allow passage across bacterial membranes.

Original languageEnglish (US)
JournalMolecular Microbiology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Permeability
Anti-Bacterial Agents
Membranes
Microbial Viability
Mycobacterium smegmatis
Osmotic Pressure
Growth
Staphylococcus aureus
Cytoplasm
Emergencies
Escherichia coli
Pharmaceutical Preparations
Genes

ASJC Scopus subject areas

  • Microbiology
  • Molecular Biology

Cite this

@article{2659f7df40b9490995201c5ba2a9cef3,
title = "An agonist of the MscL channel affects multiple bacterial species and increases membrane permeability and potency of common antibiotics",
abstract = "The bacterial MscL channel normally functions as an emergency release valve discharging cytoplasmic solutes upon osmotic stress. The channel opens and passes molecules up to 30 {\AA} and its pore is the largest of any gated channel. Opening the MscL pore inappropriately is detrimental to the bacterial cell, suggesting MscL as a potential novel drug target. A small-molecule compound, 011A, has been shown to increase sensitivity of the Escherichia coli MscL channel, slow growth, and even decrease viability of quiescent cultures. The mscL gene is highly conserved and found in the vast majority of bacterial species, including pathogens. Here, we test the hypothesis that 011A can influence the growth and viability of other bacterial species, specifically Staphylococcus aureus and Mycobacterium smegmatis, in a MscL-dependent manner. Furthermore, we demonstrate that the 011A compound can increase potency of other antibiotics, presumably by permeabilizing the membrane and allowing easier access of the antibiotic into the cytoplasm. Thus, MscL activators have potential as novel broad-spectrum antibiotics or adjuvants that work with antibiotics to selectively allow passage across bacterial membranes.",
author = "Robin Wray and Nadia Herrera and Iscla, {Irene R} and Junmei Wang and Paul Blount",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/mmi.14325",
language = "English (US)",
journal = "Molecular Microbiology",
issn = "0950-382X",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - An agonist of the MscL channel affects multiple bacterial species and increases membrane permeability and potency of common antibiotics

AU - Wray, Robin

AU - Herrera, Nadia

AU - Iscla, Irene R

AU - Wang, Junmei

AU - Blount, Paul

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The bacterial MscL channel normally functions as an emergency release valve discharging cytoplasmic solutes upon osmotic stress. The channel opens and passes molecules up to 30 Å and its pore is the largest of any gated channel. Opening the MscL pore inappropriately is detrimental to the bacterial cell, suggesting MscL as a potential novel drug target. A small-molecule compound, 011A, has been shown to increase sensitivity of the Escherichia coli MscL channel, slow growth, and even decrease viability of quiescent cultures. The mscL gene is highly conserved and found in the vast majority of bacterial species, including pathogens. Here, we test the hypothesis that 011A can influence the growth and viability of other bacterial species, specifically Staphylococcus aureus and Mycobacterium smegmatis, in a MscL-dependent manner. Furthermore, we demonstrate that the 011A compound can increase potency of other antibiotics, presumably by permeabilizing the membrane and allowing easier access of the antibiotic into the cytoplasm. Thus, MscL activators have potential as novel broad-spectrum antibiotics or adjuvants that work with antibiotics to selectively allow passage across bacterial membranes.

AB - The bacterial MscL channel normally functions as an emergency release valve discharging cytoplasmic solutes upon osmotic stress. The channel opens and passes molecules up to 30 Å and its pore is the largest of any gated channel. Opening the MscL pore inappropriately is detrimental to the bacterial cell, suggesting MscL as a potential novel drug target. A small-molecule compound, 011A, has been shown to increase sensitivity of the Escherichia coli MscL channel, slow growth, and even decrease viability of quiescent cultures. The mscL gene is highly conserved and found in the vast majority of bacterial species, including pathogens. Here, we test the hypothesis that 011A can influence the growth and viability of other bacterial species, specifically Staphylococcus aureus and Mycobacterium smegmatis, in a MscL-dependent manner. Furthermore, we demonstrate that the 011A compound can increase potency of other antibiotics, presumably by permeabilizing the membrane and allowing easier access of the antibiotic into the cytoplasm. Thus, MscL activators have potential as novel broad-spectrum antibiotics or adjuvants that work with antibiotics to selectively allow passage across bacterial membranes.

UR - http://www.scopus.com/inward/record.url?scp=85067473972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067473972&partnerID=8YFLogxK

U2 - 10.1111/mmi.14325

DO - 10.1111/mmi.14325

M3 - Article

C2 - 31177589

AN - SCOPUS:85067473972

JO - Molecular Microbiology

JF - Molecular Microbiology

SN - 0950-382X

ER -